DalsnaFinance › Analyst accuracy › Stifel › DXCM target
BTIG raises DexCom stock price target to $90 on strong Q2 results
Stifel raised its price target for DexCom shares to $95 from $90, maintaining a Buy rating.
A fact about what Stifel published, as reported by Investing.com, not a recommendation from Dalsna Finance; Stifel is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.